Abstract: An electrode with a conductive substrate and an electrocatalyst comprising zinc oxide and copper oxide supported on a carbon nanomaterial, a method of fabricating the electrode, an electrochemical cell that utilizes the electrode as a working electrode, and a process for producing propanol from CO2 with the electrochemical cell. Various combinations of embodiments of the electrode and the method of fabricating thereof, the electrochemical cell, and the process for producing propanol from CO2 is provided.

Abstract: A method for decreasing formation of one or more chemiexcitation-induced dark cyclobutane pyrimidine dimers (dCPDs) in a cell or DNA molecule in a subject, who has been exposed to UV radiation, is provided. The method comprises administering to the subject an effective amount of a dCPD quencher within 8 hours after the exposure. The dCPD quencher is selected from the group consisting of ellagic acid, Porphyra Umbilicalis Extract (including Porphyra Umbilicalis Extract (and) Sodium Lactate (and) Lecithin), mycosporine-like amino acids (MAAs) and synthetic analogues thereof, Scutellaria Baicalensis Root Extract, Chrysanthemum Morifolium Leaf Extract, ferulic acid, fused-ring cyanoacrylates, curcumin, epigallocatechin gallate, Scutellaria Baicalensis Root Extract (and) Acacia Catechu Wood Extract, sorbic acid, Polygonum Cuspidatum Root Extract, Acacia Catechu Extract, dipicolinic acid, squalene, Lonicera Japonica (Honeysuckle) Flower Extract, beta-carotene and combinations thereof.

Abstract: Apparatus for analyzing brain MRI, is disclosed. The apparatus comprises an input for receiving a first and a second MRI scans at the beginning and end of a predetermined time interval post contrast administration; a subtraction map former for forming a subtraction map from said first and said second MRI scans by analyzing said scans to distinguish between two primary populations, a slow population, in which contrast clearance from the tissue is slower than contrast accumulation, and a fast population in which clearance is faster than accumulation; and an output to provide an indication of distribution of said two primary populations, wherein said predetermined time period is at least twenty minutes.

Abstract: The present invention discloses a combined energy dissipation scaffolding structure for preventing falling rock hazards for high and steep side slope during highway construction, which belongs to the field of prevention and cure against highway disaster and post-disaster reconstruction engineering in earthquake area. The combined energy dissipation scaffolding structure mainly comprises five parts: a top surface impact-resistance system closely jointed with the existing slope surface, a top surface support system composed of 3D stereographic steel frame systems, a scaffolding body structure composed of a cross beam and support steel-pipe posts at both sides, a mountain-side anchorage system for anchoring the top surface impact-resistance system and the scaffolding body structure, and an anchoring-type steel-plate concrete composite foundation, wherein a fixed base is welded with the bottom of the steel-pipe post and is driven in the foundation soils using anchor rods.

Abstract: It is an object of the present invention to provide a compound inhibiting the binding between ALS-related mutant SOD1 and Derlin-1, a medicament comprising the compound, and a method for treating ALS by administering the medicament to a patient.

Abstract: The invention comprises the administration of a remyelinating agent to treat a demyelinating condition, such as MS. Disclosed are various remyelinating compositions which promote remyelination, oligodendrocyte differentiation, and the treatment of demyelinating conditions such as MS. In one aspect, the remyelinating compositions are selective estrogen receptor modulators with remyelinating properties. In one aspect, the remyelinating compositions are agonists of GPR56, a G-protein coupled receptor which has not previously been identified as an effector of remyelination.

Abstract: Various embodiments for fast prototyping of morphologies and controllers related to locomotion for a robotic device are disclosed.

Abstract: The inventors have unexpectedly discovered that shock and/or potential multi-organ failure due to shock can be effectively treated by administration of liquid high-dose protease inhibitor formulations to a location upstream of where pancreatic proteases are introduced into the gastrointestinal tract. Most preferably, administration is directly to the stomach, for example, via nasogastric tube under a protocol effective to treat shock by such administration without the need of providing significant quantities of the protease inhibitor to the jejunum and/or ileum.

Abstract: Disclosed is a method for modifying starch to slow down the digestion rate of modified starch. The present invention utilizes two-stage GBE treatment to convert the long straight-chain starch molecules into highly branched molecules with compact structures so as to decrease the digestion rate of the starch. During the two-stage treatment, granular starch was first treated with GBE, the treated starch was gelatinized in boiling water, and the gelatinized starch was treated with GBE for a second time, leading to an enhanced effect of GBE modification. Compared with the one-staged GBE modification, the two-stage GBE modification can further increase the content of slowly digestible starch in the modified starch and thus decrease the digestion rate of starch.

Abstract: A composition comprises: a base oil; an additive; and a drug. The additive has segments which are conjugated, e.g. covalently linked, together. A first segment facilitates solubility in the base oil, whereas a second segment facilitates drug solubility and/or modifies drug release or other behaviour. The first segment may for example comprise a poly(dimethylsiloxane)-containing moiety. The second segment may for example resemble a drug molecule. The composition may for example be used as a tamponade or as a component for a tamponade administered to the eye.

Abstract: A composition comprising the following structure: (formula I) wherein Re represents a rhenium ion having a +1 charge; (formula II) represents an uncharged bidentate bicyclic ligand bonded to the rhenium (Re) by two ring nitrogen (N) atoms; and L is a neutral ligand independently selected from CO and neutral phosphine molecules, wherein at least one of the L groups is a CO molecule; and X? represents a non-coordinating monovalent anion; wherein (formula II) is unsubstituted or substituted on any of its two rings, and said neutral phosphine molecule may or may not contain a phosphorus atom as a ring phosphorus atom; provided that, if (formula II) is unsubstituted, then one or two of said L groups are selected from said neutral phosphine molecules, with the provision that at least one of the neutral phosphine molecules has a phosphorus atom as a ring phosphorus atom. Methods for treating cancer by administering the above complex are also disclosed.

Abstract: Provided herein are compositions and methods related to treating repeat expansion diseases that feature the sequestration of Muscleblind-like (MBNL) proteins by the toxic repeat RNA transcripts within distinct nuclear foci that are expressed from the expanded repeat tracts. Certain compositions of synthetic MBLN proteins can be used to displace endogenous MBNL from the toxic RNAs or replace endogenous MBNL within the cell for normal function.

Abstract: A pressure sensing system includes at least two pressure sensing layers. The first pressure sensing layer includes a first sensing system configured in a layer, a first layer of foam having a Young's modulus and mounted between a first sensing system configured in a layer, and a second sensing system configured in a layer; at least a second pressure sensing layer including the second sensing system configured in a layer, and a second layer of foam having a Young's modulus that is greater than the Young's modulus of the first layer of foam and mounted between the second sensing system configured in a layer and a rigid substrate having a Young's modulus greater than the layer of the first sensing system, the first layer of foam, the layer of the second sensing system, and the second layer of foam. The pressure sensing system thereby defines a multi-layer pressure sensing system.

Abstract: Disclosed is a soil conditioner, comprising the following components in parts by weight: 10-20 parts of distiller's grains; 1-10 parts of cow dung; 1-10 parts of vermicompost; 1-10 parts of oil cake; 10-20 parts of dregs of decoction; 20-40 parts of fallow soil; and 20-40 parts of river sand. Also disclosed is a method for preparing a soil conditioner, comprising: first, separately fermenting distiller's grains, cow dung, vermicompost, oil cake, and dregs of decoction, and then mixing them with river sand and fallow soil for secondary solid fermentation to obtain the soil conditioner. The present invention has a remarkable restoration effect on obstructive soil, the microbial diversity index of the restored soil is increased, the microbial ecological structure of the soil is improved, and the quality of crops is enhanced.

Abstract: The present invention discloses a Fiber Bragg Grating demodulation device with a suppressed fluctuation at a variable ambient temperature and a demodulation method. The device comprises a broadband light source (1), an optical attenuator (2), a tunable F-P filter (3), a first optical fiber isolator (41), an erbium-doped optical fiber amplifier (5), an optical fiber first-stage beam splitter (6), a first optical fiber second-stage beam splitter (71), optical fiber circulators (8), FBG sensor arrays (9), a first photoelectric detector array (161), an optical fiber gas cell (10), a second optical fiber second-stage beam splitter (72), an optical fiber F-P etalon (11), a notch filter (12), an optical fiber assisted interferometer (13), a data acquisition card (17) and a processor (18).

Abstract: A quantitative method of number surface area of a graphene material includes the following steps. The graphene material is mixed with a solution to form a colloidal solution containing the graphene material. The colloidal solution is atomized to form a plurality of aerosols containing the graphene material. The size of the aerosols is screened. The screened aerosols are counted to obtain a number concentration of the screened aerosols. A surface of the screened aerosols is charged and a current amount on the surface-charged aerosols is measured. The number surface area of the graphene material is calculated based on the current amount and the number concentration.

Abstract: An ankle prosthesis comprises a foot prosthesis. A lower ankle is pivotably secured to the foot prosthesis at an ankle joint. An upper ankle is connected to the lower ankle in a manner that permits vertical movement of the upper ankle relative to the lower ankle. A coupling spring is biased in an extended condition. The coupling spring is connected at a first end to the upper ankle. A second end of the coupling spring is movable in a first condition which is engaged to the lower ankle and in a second condition engaged to the foot prosthesis. Energy is stored in compression of the coupling spring when the coupling spring is in the first condition and energy is released from the coupling spring when the coupling spring is in the second condition.

Abstract: The present invention relates to a transfer chute (100) for granular material, comprising a chute body defining a flow pathway (120) for granular material, a raised portion (110) having an inclined surface (111), and a splitter member (130) arranged proximal to the raised portion (110) for, in use, dividing a flow of granular material over the raised portion into first portion in first conduit (100) and a second portion in a second conduit (300). In some embodiments, a channel (150) is disposed between the first and second conduits (100; 300) to transpose a vertical arrangement of first and second portions of granular material within the chute (10). In this way, separation by particle size or density in the flow may be reversed.

Abstract: Pateamine A derivatives, pharmaceutical compositions that include the derivatives, and methods for treating chronic lymphocytic leukemia using the derivatives.

Abstract: An assay and a method for identifying a prebiotic to treat a subject in need thereof to promote intestinal barrier integrity or to blunt an inflammatory response are provided.